Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BRCA2 gene region made public to scupper patent claims

This article was originally published in Clinica

Executive Summary

A 900,000 bp DNA sequence thought to contain the breast cancer gene BRCA2 has been published on the Internet in a bid to foil patent applications. Writing in Nature (November 30th) Dr John Sulston, director of the Sanger Centre who together with researchers at Washington University, Missouri, published the sequence, says: "It will not be helpful to medicine if, by the year 2003, control of every single gene is tied up by one company or another for 20 years."

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094485

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel